Teriparatide acetate (Human parathyroid hormone 1-34), the acetate salt form of teriparatide (HSDB 7367; ZT034; Forteo) consisting of the first 34 amino acids of PHT, is a potent parathyroid hormone (PTH) agonist approved in 2017 by FDA as an anabolic agent for the treatment of osteoporosis. As a PHT agonist, it inhibits PHT with an IC50 of 2 nM in HEK293 cells.

纯度：≥98%

CAS：99294-94-7